MDM2 inhibitors for cancer therapy
Top Cited Papers
- 1 January 2007
- journal article
- review article
- Published by Elsevier in Trends in Molecular Medicine
- Vol. 13 (1) , 23-31
- https://doi.org/10.1016/j.molmed.2006.11.002
Abstract
No abstract availableKeywords
This publication has 81 references indexed in Scilit:
- Structure-Based Design of Spiro-oxindoles as Potent, Specific Small-Molecule Inhibitors of the MDM2−p53 InteractionJournal of Medicinal Chemistry, 2006
- p53 Activation by Small Molecules: Application in OncologyJournal of Medicinal Chemistry, 2005
- Discovery and Cocrystal Structure of Benzodiazepinedione HDM2 Antagonists That Activate p53 in CellsJournal of Medicinal Chemistry, 2005
- Small molecule RITA binds to p53, blocks p53–HDM-2 interaction and activates p53 function in tumorsNature Medicine, 2004
- The ubiquitin ligase COP1 is a critical negative regulator of p53Nature, 2004
- Small-molecule inhibitors of protein–protein interactions: progressing towards the dreamNature Reviews Drug Discovery, 2004
- The role of p53 in determining sensitivity to radiotherapyNature Reviews Cancer, 2003
- Live or let die: the cell's response to p53Nature Reviews Cancer, 2002
- Regulation of p53 stability by Mdm2Nature, 1997
- Mdm2 promotes the rapid degradation of p53Nature, 1997